In response to queries and concerns regarding the approval process for Transcatheter Aortic Valve Implantation/Replacement (TAVI/TAVR) and Coronary Intra Vascular Lithotripsy (IVL) or Shock Wave Lithotripsy procedures under the Central Government Health Scheme (CGHS), the Ministry of Health and Family Welfare has issued a clarification. This clarification was issued through an Office Memorandum (OM) dated December 27, 2023.
In an Office Memorandum (OM) dated 19th December 2023, CGHS package rates for TAVI/TAVR and IVL procedures were defined. The memorandum highlighted the need for approval from the Director, CGHS, in consultation with the Special Technical Committee (STC) for these specific medical interventions.
The clarification emphasizes that the approval process, as outlined in the aforementioned OM, will be in effect until further orders. The reason cited is that the formulation of comprehensive guidelines for these procedures is currently under consideration.
Healthcare providers empanelled with CGHS are advised to take note of this clarification. The Additional Directors, CGHS, are instructed to disseminate the contents of this Office Memorandum to all empanelled Health Care Organizations (HCO).
This clarification aims to streamline the process of obtaining approval for TAVI/TAVR and IVL procedures, ensuring that the highest standards of patient care are maintained under the CGHS.
